• OPEN AN ACCOUNT
Indian Indices
Nifty
22,326.90 203.25
(0.92%)
Sensex
73,651.35 655.04
( 0.90%)
Bank Nifty
47,124.60 338.65
( 0.72%)
Nifty IT
34,898.15 153.80
( 0.44%)
Global Indices
Nasdaq
16,399.52 83.82
(0.51%)
Dow Jones
39,760.08 477.75
(1.22%)
Hang Seng
16,541.42 148.58
(0.91%)
Nikkei 225
40,168.07 -594.66
(-1.46%)
Forex
USD-INR
83.33 -0.11
(-0.13%)
EUR-INR
90.34 0.01
(0.02%)
GBP-INR
105.32 -0.01
(-0.01%)
JPY-INR
0.55 0.00
(-0.18%)

EQUITY - MARKET SCREENER

Sun Pharma subsidiary to acquire 12.5% stake in WRS Bioproducts
05-Mar-21   15:46 Hrs IST

WRS Bioproducts is an early stage company based in Australia, developing novel technologies to produce and commercialize supplements and nutraceutical ingredients from diverse algae species.

The cost of the said acquisition is 2 million Australian dollars and the company expects to complete the same by 15 March 2021.

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

The drug major reported an 102.78% jump in consolidated net profit to Rs 1,852.48 crore on 8.3% rise in revenue from operations to Rs 8,836.78 crore in Q3 FY21 over Q3 FY20.

The scrip fell 1.24% to end at Rs 610.95 on the BSE on Friday.

Powered by Capital Market - Live News